This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
A new study finds that when epigallocatechin gallate, when diluted in skim milk or other milk complexes, remains bioactive and continues to reduce colon cancer cell proliferation in culture at concentrations higher than 0.03mg of EGCG/mL.
Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages.
Postmenopausal women who reported the highest intake of sugar-sweetened beverages had a 78% increased risk for estrogen-dependent type I endometrial cancer.